MarginsXMarginsX
Home › Markets › BIXT

Bioxytran, Inc (BIXT)

BIXT is quoted over the counter, not listed on an exchange. Bioxytran, Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.0230
+4.5% on the day
1-year return
-67.1%
Market cap
$2.6M
Nano cap. From the Nov 13, 2026 close × 114.7M shares (10-Q cover page, Aug 14, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerBIXT, quoted over the counter
SEC CIK0001445815
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressNeedham, MA
Incorporated inNV

Warning signs

Cash runway
2.4 months
$177K cash at June 30, 2026
Share count, 1 year
+28.9%
2025-08-08 to 2026-08-14 · -13.5% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$126K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-08-14
Cash and burn$177K cash; operating cash flow -$219K a quarter.Report 2026-06-30
Shares outstanding114,695,220 (2026-08-14); 88,992,243 a year earlier; 132,535,294 three years earlier.Cover page 2026-08-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorFruci & Associates II, PLLC, Spokane, Washington, United StatesPCAOB Form AP 2026-04-21
Late filings, 12 months1 NT noticeNT 10-K 2026-04-01
Insider trades, 12 monthsBought $126K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$620K-$350K$177K$1.2MNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$2.1M-$239K$463K$1.2MNeeds four quarters10-Q 2026-08-14
Q4 2025
2025-12-31
Not filed-$522K-$237K$510K$1.2MNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$283K-$49K$14K$805KNeeds four quarters10-Q 2025-11-14
Q2 2025
2025-06-30
Not filed$35K-$73K$3K$853KNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$1.4M-$167K$4K$853KNeeds four quarters10-Q 2026-08-14
Q4 2024
2024-12-31
Not filed-$752K-$128K$5K$853KNeeds four quarters10-K 2026-04-15
Q3 2024
2024-09-30
Not filed-$392K-$74K$35K$805KNeeds four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-02-18
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-11-16
Latest proxyDEF 14A2009-10-13

Source: SEC EDGAR submissions feed, 471 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier